Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02445378 · ClinicalTrials.gov registry record · NA

Aromatherapy and Essential Oils in Improving Insomnia and Other Symptoms in Patients With Newly Diagnosed Acute Leukemia Undergoing Chemotherapy

A NA study, sponsored by Ohio State University Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
48
Enrollment target

NCT02445378 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 48 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02445378, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

This randomized clinical trial studies aromatherapy and essential oils in improving insomnia and other symptoms in patients with newly diagnosed acute leukemia. Aromatherapy and essential oils may help improve insomnia and other complications caused by chemotherapy.

Interventions

  • OTHER Placebo
  • OTHER Questionnaire Administration
  • PROCEDURE Aromatherapy and Essential Oils

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2014-12-28
Est. Completion 2016-11-05
Phase NA

What the Registry Record Tells You About NCT02445378

The ClinicalTrials.gov registry entry for NCT02445378 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.

NCT02445378 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02445378 about?

NCT02445378 is a clinical study titled "Aromatherapy and Essential Oils in Improving Insomnia and Other Symptoms in Patients With Newly Diagnosed Acute Leukemia Undergoing Chemotherapy". This randomized clinical trial studies aromatherapy and essential oils in improving insomnia and other symptoms in patients with newly diagnosed acute leukemia. Aromatherapy and essential oils may help improve insomnia and other complications caused by chemotherapy.

What is the current status of trial NCT02445378?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2014-12-28. Estimated completion is 2016-11-05.

What interventions are being tested in trial NCT02445378?

The interventions under investigation include: Placebo (OTHER), Questionnaire Administration (OTHER), Aromatherapy and Essential Oils (PROCEDURE).

Who is sponsoring clinical trial NCT02445378?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.